Caxton Associates (New York)’s Concentrix CNXC Stock Holding History
Bought
Maintained
Sold
Other funds holding CNXC
PCOC
IC
Caxton Associates (New York)'s CNXC Position: Q3 2023 in Review
Caxton Associates (New York) sold out of Concentrix (CNXC) in Q3 2023, closing a stake of 3,404 shares — an estimated $275K sold.
Caxton Associates (New York) first reported a position in CNXC in Q2 2023 and held it in 1 quarter. The position peaked at $275K in Q2 2023. 302 funds tracked by Wall St. Rank hold CNXC as of Q3 2023.
- Caxton Associates (New York) reported no remaining Concentrix position as of Q3 2023 after selling out during the quarter.
- Caxton Associates (New York) sold 3,404 Concentrix shares in Q3 2023, an estimated $275K.
- Caxton Associates (New York) first reported a position in Concentrix in Q2 2023 and held it in 1 quarter.
- Caxton Associates (New York)'s Concentrix position peaked at $275K in Q2 2023.
- 302 funds tracked by Wall St. Rank held Concentrix as of Q3 2023.
Based on Caxton Associates (New York)'s 13F filing for Q3 2023, filed 14 Nov 2023.